Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

APLT Stock Forecast, Price Targets, Chart, Dividends & Analysis

Applied Therapeutics Inc. logo

Applied Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.49
 
USD
  
0.01
  
(1.17%)
Previous close: 0.4852  Open: 0.497  Bid: 0.47  Ask: 0.4895
52 week range    
0.30   
   10.62
Mkt Cap: 62 M  Avg Vol (90 Days): 2,159,973
Last updated: Friday 16th May 2025

Stock Rankings

43
MarketXLS Rank
60
Value
40
Technical
31
Quality
How are these ranks calculated?
Search for a stock

Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

APLT Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23Dec-24
AccruedPreferredStockDividends46 M94 M106 M83 M
Basic EPS from continuing operations-4.28-4.12-2.18-1.42-0.76
Basic EPS total-4.28-4.12-2.18-1.42-0.76
Basic weighted shares outstanding13 M22 M26 M38 M84 M140 M
Diluted EPS total-3.55-4.28-4.12-2.18-1.42-0.76
Diluted normalized net income/share-3.55-4.12-2.18-1.42-0.76
Diluted weighted shares outstanding13 M26 M38 M84 M140 M
GainOnSaleOfSecurity1000.050000.016000.0
GeneralAndAdministrativeExpense13 M33 M43 M27 M21 M56 M
Gross operating profit10 M455000.0
Income before tax-46 M-94 M-106 M-83 M-120 M-106 M
Interest income93000.0559000.0555000.0685000.01 M4 M
MiscOtherSpecialCharges-24000.0-54000.0-521000.0-243000.0-57 M-5 M
Net income from total operations-46 M-94 M-106 M-83 M-120 M-106 M
NetIncomeCommonStockholders-91 M-94 M-106 M-83 M-120 M-106 M
NetIncomeContinuousOperations-46 M-94 M-106 M-83 M-120 M-106 M
NetNonOperatingInterestIncomeExpense93000.0559000.0555000.0685000.01 M4 M
Normalized income-105 M
Operating income-46 M-94 M-106 M-83 M-65 M-104 M
Operating income before depreciation (EBITDA)-46 M-94 M-105 M-83 M-117 M-105 M
OperatingExpense46 M94 M106 M83 M75 M105 M
Other income net24000.054000.0521000.0-243000.057 M5 M
OtherGandA13 M33 M43 M27 M21 M56 M
OtherOperatingExpenses-46 M94 M106 M83 M
OtherunderPreferredStockDividend46 M94 M106 M83 M
PreferredStockDividends46 M94 M106 M83 M
Research & development expense32 M62 M63 M56 M54 M49 M
ResearchExpense32 M62 M63 M56 M54 M49 M
SalariesAndWages-6 M
Selling Gen & administrative expense13 M33 M43 M27 M21 M56 M
Total Income available for interest expense (EBIT)-46 M-94 M-106 M-83 M-120 M-106 M
Total common shares outstanding22 M26 M26 M48 M106 M142 M
Total net income-46 M-94 M-106 M-83 M-120 M-106 M
Total ordinary shares142 M142 M142 M142 M142 M142 M
Total revenues10 M455000.0
TotalExpenses46 M94 M106 M83 M75 M105 M
TotalRevenue10 M455000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader